All episodes

In this episode, Elizabeth Robertson, Director of Research and Clinical at Diabetes UK, and Rachel Connor, Director of Research Partnerships at Breakthrough T1D, discuss why prevention has become one of the biggest topics in type 1 diabetes research.

They explore how decades of charity-funded research have led to exciting advances in immunotherapies that can delay the onset of type 1 diabetes, the growing importance of early screening programmes, and the promise of stem cell-derived beta cell therapies. They also explain why collaboration between researchers, charities, healthcare professionals, policymakers and people living with diabetes will be essential to ensure these breakthroughs...

In this episode, former EASD President Prof. Stefano Del Prato joins host Vivienne Parry to reflect on leading EASD during the unprecedented challenges of the COVID-19 pandemic.

He shares how EASD rapidly transformed its Annual Meeting into a successful virtual event, unexpectedly reaching more than 20,000 participants worldwide and strengthening connections with the global diabetes community. The conversation explores how these experiences led to the creation of the EASD Global Council, expanded international collaboration and new initiatives that continue to shape the organisation today.

Prof. Del Prato also discusses the enduring value of face-to-face scientific meetings, the importance of bringing...

In this episode, Prof. João Filipe Raposo (Portugal) and Prof. Harald Sourij (Austria) join Vivienne Parry to debate one of the most discussed topics in modern diabetes care: the role of artificial intelligence.

The conversation explores how AI is already being used to support diabetes management, including automated insulin delivery systems, continuous glucose monitoring and risk prediction. At the same time, the speakers examine the challenges of translating AI research into everyday clinical practice, highlighting the need for robust evidence, high-quality data and meaningful patient outcomes.

They also discuss data privacy, regulation, patient trust and why human expertise and empathy...

In this episode, EASD tv host Vivienne Parry speaks with Prof. Daisuke Yabe (Kyoto University) about the growing global impact of EASD and the importance of international collaboration in diabetes research.

Prof. Yabe explains the key differences between diabetes phenotypes in Europe and East Asia, highlighting how obesity, insulin resistance and beta cell dysfunction vary across populations. He discusses how sharing these perspectives is driving better research, stronger international partnerships and improved diabetes care worldwide.

The conversation also explores one of the most exciting developments in regenerative medicine: iPS cell-derived islet transplantation. Professor Yabe shares how clinical trials in Japan...

In this episode, Prof. Thomas Karagiannis and Dr Francesco Zaccardi take us behind the scenes of clinical guideline development at EASD. As methodologists involved in creating the first EASD clinical guidelines, they explain how rigorous evidence review, transparent processes and careful management of conflicts of interest help ensure recommendations are trustworthy and evidence-based.

The discussion explores the newly developed guideline on diabetes distress, upcoming guidance on continuous glucose monitoring in type 2 diabetes, and future recommendations on diabetes prevention. Along the way, Thomas and Francesco highlight the importance of patient involvement, the role of systematic reviews and meta-analyses, and the...

In this episode, Dame Melanie Davies and Prof. Amanda Adler discuss the development of a new EASD clinical guideline on continuous glucose monitoring (CGM) in people living with type 2 diabetes.

As CGM becomes increasingly available, clinicians, researchers, and policymakers are seeking clear evidence-based guidance on its role in diabetes management. The discussion explores why CGM was selected as a priority topic, how guideline questions are developed, the importance of patient involvement, and the rigorous process used to evaluate clinical evidence.

The conversation also highlights the broader outcomes that matter to people living with diabetes (including quality of life, confidence...

In this episode, Prof. Eberhard Standl marks an extraordinary milestone - 50 years since attending his first EASD Congress. Looking back on a career spanning five decades, he shares how diabetes care has evolved from the challenges of diabetic ketoacidosis in the 1970s to today's advances in continuous glucose monitoring, hybrid closed-loop systems, immunotherapies, and the potential reversal of type 2 diabetes.

Prof. Standl discusses the enduring importance of lifestyle interventions, the value of long-term partnerships between clinicians and people living with diabetes, and emerging research linking diabetes, obesity, metabolism, and cancer. He also reflects on the collaborative spirit of...

In this episode, Prof. Richard Holt and Prof. Kirsten Nørgaard discuss the updated EASD-ADA Consensus Report on Type 1 Diabetes, a comprehensive update designed to provide timely, evidence-based guidance for healthcare professionals managing type 1 diabetes.

They explain how consensus reports differ from formal clinical guidelines, why they remain an important tool for advancing diabetes care, and how the latest update reflects major developments in diabetes technology and clinical practice since the original report was published in 2021.

The conversation explores stronger recommendations for continuous glucose monitoring (CGM) and automated insulin delivery systems, as well as new sections covering obesity...

In this episode, Prof. Partha Kar joins EASD TV Host, Vivienne Parry, to explore the growing role of social media in healthcare and diabetes care.

From combating misinformation and amplifying patient voices to navigating online abuse and professional risks, Prof. Kar shares why he believes clinicians should engage - not retreat - from digital platforms. He discusses how social media helped shape conversations around continuous glucose monitoring (CGM) access in the UK, why visibility and accountability matter in healthcare leadership and how platforms like X, LinkedIn and Substack are changing the way research and medical information are shared.

The conversation...

In this episode, Prof. Steven Kahn, Editor-in-Chief of Diabetes Care, and Deputy Editor Dr John Buse discuss their powerful editorial examining how political decisions, healthcare reform, and attacks on diversity, equity, and inclusion (DEI) could impact diabetes care and biomedical research in the United States and globally.

The conversation explores concerns around cuts to NIH and CDC funding, changes to public health policy, and the implications for chronic disease research, healthcare access, and health equity. They also discuss why diversity matters in diabetes research, the importance of peer-reviewed science, and why senior leaders in medicine must continue speaking out in...